At the following events you have the chance to meet us personally. You can click on the event for further information, contact us or set a reminder.
Australian and New Zealand Society of Nuclear Medicine (ANZSNM) in Sydney, Australia
This is the 51st Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine (ANZSNM), which will be moving to a unique and exciting new structure combining the best of face to face and virtual technology. The theme of the meeting is Key Collaborations, Key Impacts - Unlocking the Potential of Nuclear Medicine
Go to ANZSM website
The European-African Hepato-Pancreato-Biliary Association (E-AHPBA) in Bilbao, Spain
In addition to state-of-the-art lectures and interdisciplinary symposia, the meeting will give clinicians and scientists from Europe and all over the world the opportunity to present and exchange their HPB experience with particular emphasis on the integration of young surgeons
Go to E-AHPBA website
European Conference on Embolotherapy (ET) in Nice, France
The ET programme covers the entire spectrum of established embolotherapies, as well as the field’s hot topics and trends for the future.
Go to ET website
ESMO WCGIC in Barcelona, Spain, Europe
The ESMO WCGIC (World Congress on Gastrointestinal Cancer) is the premier global event in the field – encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to the care of patients with gastrointestinal cancer, including screening, diagnosis and the latest management options for common and uncommon tumours.
Go to ESMO WCGIC website
Americas Hepato-Pancreato-Biliary Association (AHPBA) in Miami Beach, FL
The mission of Americas Hepato-Pancreato-Biliary Association is to disseminate knowledge, foster research and innovation, advance education and training and encourage multidisciplinary collaboration.
Go to AHPBA website
SGCR & WIRES
Singapore Congress of Radiology and Workshops in Interventional Radiology Education Singapore in Singapore
Go to SGCR & WIRES website
The Australasian Gastro-Intestinal Trials Group, Adelaide, Australia
The AGITG Annual Scientific Meeting is widely known throughout Australasia as the premier meeting in the gastro-intestinal (GI) cancer space. The AGITG is the only research organisation in the Australasian region with a focus on gastro-intestinal cancers.
Go to AGITG website
Now leaving sirtex.com
You are about to leave the Sirtex Web site. This link is provided to you as a service and will take you to a site maintained by a third party who is solely responsible for the content.
Please be aware that Sirtex takes no responsibility for content of these external sites, nor do we endorse, warrant or guarantee the products, services or information described or offered on other internet sites.
Click 'Continue' to proceed to the third-party Web site.
Now leaving sirtex.com
You are about to leave the Sirtex Website. This link is provided to you as a service and will take you to the Sirtex Virtual Booth.
Sirtex is responsible for the content of the Virtual Booth, which is hosted on a website maintained by a third-party. Except for Sirtex’s Virtual Booth experience, please be aware that Sirtex takes
no responsibility for the other content of these external sites, nor do we endorse, warrant, or guarantee the products, services or information described or offered on other internet sites.
You are now leaving your current sirtex.com region
The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region.
Any products discussed herein may have different approved product labeling; therefore, any information provided may not be appropriate for use in your region.
Click 'Continue' to proceed to the other Sirtex region Web site.
Effective May 7, 2021, SIR-Spheres will have the following indication for use:
SIR-Spheres Y-90 resin microspheres are indicated for the treatment of unresectable hepatocellular carcinoma (HCC) and
unresectable metastatic liver tumors from primary colorectal cancer in patients refractory to or intolerant of chemotherapy.